{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:23:14Z","timestamp":1785032594172,"version":"3.55.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.placenta.2020.07.012","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T22:16:41Z","timestamp":1595629001000},"page":"50-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The impact of intrauterine growth restriction on cytochrome P450 enzyme expression and activity"],"prefix":"10.1016","volume":"99","author":[{"given":"Grace M.","family":"McBride","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Yin","family":"Soo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack R.T.","family":"Darby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara J.","family":"Varcoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna L.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib1","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1016\/S2214-109X(18)30565-5","article-title":"National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis","volume":"7","author":"Blencowe","year":"2019","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.placenta.2020.07.012_bib2","series-title":"International Statistical Classification of Diseases and Related Health Problems","author":"World Health Organisation","year":"1992"},{"key":"10.1016\/j.placenta.2020.07.012_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/rep.0.1220195","article-title":"Fetal growth restriction: adaptions and consequences","volume":"122","author":"McMillen","year":"2001","journal-title":"Reproduction"},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.semperi.2007.11.003","article-title":"The IUGR newborn","volume":"32","author":"Rosenberg","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpobgyn.2009.05.003","article-title":"Aetiology and pathogenesis of IUGR","volume":"23","author":"Sankaran","year":"2009","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2020.07.012_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/jrf.0.0070289","article-title":"Studies on the placenta of the sheep (Ovis Aries L.)","volume":"7","author":"Alexander","year":"1964","journal-title":"J. Reprod. Fertil."},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1440-1681.2008.04975.x","article-title":"Sheep models of intrauterine growth restriction: fetal adaptations and consequences","volume":"35","author":"Morrison","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"12","key":"10.1016\/j.placenta.2020.07.012_bib8","article-title":"Induction of controlled hypoxic pregnancy in large mammalian species","volume":"3","author":"Brain","year":"2015","journal-title":"Phys. Rep."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/17474108.3.6.719","article-title":"Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size","volume":"3","author":"Reeves","year":"2008","journal-title":"Expet Rev. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/rep.1.00033","article-title":"Endocrine mechanisms of intrauterine programming","volume":"127","author":"Fowden","year":"2004","journal-title":"Reproduction"},{"issue":"Suppl","key":"10.1016\/j.placenta.2020.07.012_bib11","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.domaniend.2016.02.014","article-title":"Glucocorticoid programming of intrauterine development","volume":"56","author":"Fowden","year":"2016","journal-title":"Domest. Anim. Endocrinol."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.theriogenology.2007.09.021","article-title":"The pregnant sheep as a model for human pregnancy","volume":"69","author":"Barry","year":"2008","journal-title":"Theriogenology"},{"issue":"6998","key":"10.1016\/j.placenta.2020.07.012_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature02725","article-title":"Developmental plasticity and human health","volume":"430","author":"Bateson","year":"2004","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000438451","article-title":"Brain-sparing in intrauterine growth restriction: considerations for the neonatologist","volume":"108","author":"Cohen","year":"2015","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00246-002-0404-0","article-title":"Autoregulation of cerebral blood flow in fetuses with congenital heart disease: the brain sparing effect","volume":"24","author":"Donofrio","year":"2003","journal-title":"Pediatr. Cardiol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib16","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1152\/ajpregu.00036.2014","article-title":"Impact of chronic hypoxemia on blood flow to the brain, heart, and adrenal gland in the late-gestation IUGR sheep fetus","volume":"308","author":"Poudel","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib17","doi-asserted-by":"crossref","first-page":"367 e1","DOI":"10.1016\/j.ajog.2015.10.004","article-title":"The hemodynamics of late-onset intrauterine growth restriction by MRI","volume":"214","author":"Zhu","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1095\/biolreprod.108.073569","article-title":"Intrauterine growth restriction and differential patterns of hepatic growth and expression of IGF1, PCK2, and HSDL1 mRNA in the sheep fetus in late gestation","volume":"80","author":"Gentili","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.placenta.2020.07.012_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.placenta.2018.03.003","article-title":"Oxidative stress in placental pathology","volume":"69","author":"Schoots","year":"2018","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrendo.2014.73","article-title":"Glucocorticoids and fetal programming part 1: Outcomes","volume":"10","author":"Moisiadis","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.placenta.2020.07.012_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.theriogenology.2020.01.080","article-title":"Cardiorespiratory consequences of intrauterine growth restriction: influence of timing, severity and duration of hypoxaemia","author":"Darby","year":"2020","journal-title":"Theriogenology"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.13190","article-title":"Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)","volume":"42","author":"Lees","year":"2013","journal-title":"Ultrasound Obstet. Gynecol.: Off. J. Int. Soc. Ultrasound . Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.07.012_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2393-14-63","article-title":"Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study","volume":"14","author":"Unterscheider","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/physiol.00050.2005","article-title":"Intrauterine programming of physiological systems: causes and consequences","volume":"21","author":"Fowden","year":"2006","journal-title":"Physiology"},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/physrev.00053.2003","article-title":"Developmental origins of the metabolic syndrome: prediction, plasticity, and programming","volume":"85","author":"McMillen","year":"2005","journal-title":"Physiol. Rev."},{"issue":"8663","key":"10.1016\/j.placenta.2020.07.012_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","article-title":"Weight in infancy and death from ischaemic heart disease","volume":"2","author":"Barker","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00399095","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth","volume":"36","author":"Barker","year":"1993","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1471-0528.2000.tb13336.x","article-title":"The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study","volume":"107","author":"Zeitlin","year":"2000","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra0708473","article-title":"Effect of in utero and early-life conditions on adult health and disease","volume":"359","author":"Gluckman","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib30","first-page":"158","article-title":"Fetal origins of adult disease","volume":"41","author":"Calkins","year":"2011","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"issue":"2\u20133","key":"10.1016\/j.placenta.2020.07.012_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.exger.2010.08.031","article-title":"Early-life origin of adult disease: evidence from natural experiments","volume":"46","author":"Vaiserman","year":"2011","journal-title":"Exp. Gerontol."},{"issue":"134","key":"10.1016\/j.placenta.2020.07.012_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phrs.2018.06.003","article-title":"Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period","volume":"134","author":"Soo","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.placenta.2020.07.012_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2018.02.001","article-title":"Does poor fetal growth influence the extent of fetal exposure to maternal medications?","volume":"130","author":"Soo","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.semperi.2015.08.002","article-title":"Epidemiology of medications use in pregnancy","volume":"39","author":"Ayad","year":"2015","journal-title":"Semin. Perinatol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajmg.c.30309","article-title":"We don't know what we don't study: the case for research on medication effects in pregnancy","volume":"157C","author":"Parisi","year":"2011","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/17425255.3.6.819","article-title":"Drug transport across the placenta, role of the ABC drug efflux transporters","volume":"3","author":"Behravan","year":"2007","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib38","doi-asserted-by":"crossref","first-page":"51 e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.07.012_bib39","author":"AIHW"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/j.2055-2335.2010.tb00557.x","article-title":"Hospital pharmacy dispensing records for pharmacoepidemiology research into late gestation exposure to antidepressants","volume":"40","author":"Grzeskowiak","year":"2010","journal-title":"J. Pharm. Pract. Res."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib41","doi-asserted-by":"crossref","first-page":"194 e1","DOI":"10.1016\/j.ajog.2007.07.036","article-title":"Use of antidepressant medications during pregnancy: a multisite study","volume":"198","author":"Andrade","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.genhosppsych.2012.12.010","article-title":"National trends in antidepressant medication treatment among publicly insured pregnant women","volume":"35","author":"Huybrechts","year":"2013","journal-title":"Gen. Hosp. Psychiatr."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bpobgyn.2015.04.002","article-title":"Heart disease in pregnancy","volume":"29","author":"Emmanuel","year":"2015","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"9","key":"10.1016\/j.placenta.2020.07.012_bib44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0607-5","article-title":"Gestational diabetes mellitus: an updated overview","volume":"40","author":"Chiefari","year":"2017","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/pds.4185","article-title":"Antiemetic use among pregnant women in the United States: the escalating use of ondansetron","volume":"26","author":"Taylor","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.placenta.2020.07.012_bib46","article-title":"Antenatal corticosteroids to reduce neonatal morbidity and mortality","author":"Royal College of Obstetrics and Gynaecologists","year":"2010","journal-title":"Green-top Guideline"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib48","first-page":"471","article-title":"Placental transfer and metabolism of betamethasone in human pregnancy","volume":"49","author":"Anderson","year":"1977","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib49","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1210\/en.2006-1058","article-title":"The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus","volume":"148","author":"Miller","year":"2007","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.placenta.2020.07.012_bib50","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/dmd.105.004309","article-title":"Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use","volume":"33","author":"Samtani","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.placenta.2020.07.012_bib51","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1177\/1933719116660842","article-title":"Risk of respiratory distress syndrome and efficacy of glucocorticoids: are they the same in the normally grown and growth-restricted infant?","volume":"23","author":"McGillick","year":"2016","journal-title":"Reprod. Sci."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.reprotox.2012.01.013","article-title":"Maternal undernutrition reduces P-glycoprotein in Guinea pig placenta and developing brain in late gestation","volume":"33","author":"Soo","year":"2012","journal-title":"Reprod. Toxicol."},{"issue":"Suppl 2","key":"10.1016\/j.placenta.2020.07.012_bib53","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.placenta.2012.05.010","article-title":"The emerging role of mTORC1 signaling in placental nutrient-sensing","volume":"33","author":"Jansson","year":"2012","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.clpt.6100448","article-title":"Drug safety in pregnant women and their babies: ignorance not bliss","volume":"83","author":"Chambers","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clpt.2005.08.016","article-title":"Women in early-phase clinical drug trials: have things changed over the past 20 years?","volume":"78","author":"Fleisch","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.placenta.2020.07.012_bib57","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","article-title":"Lithium placental passage and obstetrical outcome: implications for clinical management during late gestation","volume":"162","author":"Newport","year":"2005","journal-title":"AM J Psychiatr."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40345-018-0135-7","article-title":"Lithium during pregnancy and after delivery: a review","volume":"6","author":"Poels","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ogrm.2008.05.005","article-title":"Drug-prescribing challenges during pregnancy, Obstetrics","volume":"18","author":"Freyer","year":"2008","journal-title":"Gynaecol. Reprod. Med."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00228-011-1154-9","article-title":"Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy","volume":"68","author":"Grzeskowiak","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.placenta.2020.07.012_bib61","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pds.1995","article-title":"Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens","volume":"19","author":"Colvin","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0035-1556745","article-title":"Identifying human teratogens: an update","volume":"4","author":"Alwan","year":"2015","journal-title":"J. Pediatr. Genet."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","volume":"157C","author":"Adam","year":"2011","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib64","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bcp.12207","article-title":"Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19","volume":"77","author":"Ke","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.curobgyn.2005.03.005","article-title":"Drug-prescribing challenges during pregnancy","volume":"15","author":"Weiner","year":"2005","journal-title":"Curr. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib66","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ajog.2016.01.187","article-title":"Clinical management of medications in pregnancy and lactation","volume":"214","author":"Temming","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/FTD.0b013e318261c372","article-title":"Therapeutic drug monitoring in pregnancy","volume":"34","author":"Matsui","year":"2012","journal-title":"Ther. Drug Monit."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib69","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/17425255.2.6.947","article-title":"Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation","volume":"2","author":"Anderson","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2133\/dmpk.24.25","article-title":"Mechanistic basis of using body size and maturation to predict clearance in humans","volume":"24","author":"Anderson","year":"2009","journal-title":"Drug Metabol. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1067\/mcp.2002.120250","article-title":"Pharmacokinetics of betamethasone in twin and singleton pregnancy","volume":"71","author":"Ballabh","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clinthera.2011.11.022","article-title":"Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects","volume":"34","author":"Salem","year":"2012","journal-title":"Clin. Therapeut."},{"issue":"8","key":"10.1016\/j.placenta.2020.07.012_bib73","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1053\/j.semperi.2014.08.013","article-title":"Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations","volume":"38","author":"Feghali","year":"2014","journal-title":"Semin. Perinatol."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib74","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2133\/dmpk.DMPK-12-NT-018","article-title":"Mechanisms of CYP3A induction by glucocorticoids in human fetal liver cells","volume":"27","author":"Matsunaga","year":"2012","journal-title":"Drug Metabol. Pharmacokinet."},{"issue":"9","key":"10.1016\/j.placenta.2020.07.012_bib75","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/FPC.0b013e32810f2e58","article-title":"Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues","volume":"17","author":"Bi\u00e8che","year":"2007","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.placenta.2020.07.012_bib76","author":"Flockhart"},{"key":"10.1016\/j.placenta.2020.07.012_bib77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-2952(95)02184-1","article-title":"Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta","volume":"51","author":"Hakkola","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/jpm7040018","article-title":"Variation in CYP2A6 activity and personalized medicine","volume":"7","author":"Tanner","year":"2017","journal-title":"J. Personalized Med."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib79","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0928-0987(99)00031-7","article-title":"Controlling drug delivery across the placenta","volume":"8","author":"Audus","year":"1999","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.placenta.2020.07.012_bib81","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defect Res. C Embryo Today"},{"issue":"12","key":"10.1016\/j.placenta.2020.07.012_bib82","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1517\/17425250903304049","article-title":"Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues","volume":"5","author":"Myllynen","year":"2009","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.placenta.2020.07.012_bib83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fphar.2012.00126","article-title":"Drug interactions at the human placenta: what is the evidence?","volume":"3","author":"Rubinchik-Stern","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1389200043489171","article-title":"Placental drug transporters","volume":"5","author":"Unadkat","year":"2004","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.placenta.2020.07.012_bib85","article-title":"Placental structure, function and drug transfer","author":"Griffiths","year":"2014","journal-title":"Cont. Educ. Anaesth. Crit. Care Pain"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib86","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1008656928861","article-title":"Mechanisms of drug transfer across the human placenta","volume":"20","author":"van der Aa","year":"1998","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.placenta.2020.07.012_bib87","first-page":"152","article-title":"Placental permeability for drugs of abuse and their metabolites","volume":"154","author":"Olsen","year":"1995","journal-title":"NIDA Res. Monogr."},{"issue":"2S","key":"10.1016\/j.placenta.2020.07.012_bib88","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.07.012_bib89","doi-asserted-by":"crossref","unstructured":"B.S. Saini, J.L. Morrison, M. Seed, Gas exchange across the placenta, in: S. Lapinsky, L. Plante (Eds.), Respiratory Disease in Pregnancy, Cambridge University Press2020, pp. 34-57.","DOI":"10.1017\/9781108163705.005"},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib90","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cbi.2013.03.007","article-title":"Placental ABC transporters, cellular toxicity and stress in pregnancy","volume":"203","author":"Aye","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib91","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"1998","journal-title":"Reprod. Toxicol."},{"issue":"6\u20137","key":"10.1016\/j.placenta.2020.07.012_bib92","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","article-title":"Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib93","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1111\/jcmm.13646","article-title":"Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta","volume":"22","author":"Lye","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.placenta.2020.07.012_bib94","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.placenta.2013.05.010","article-title":"Effect of oxygen on multidrug resistance in the first trimester human placenta","volume":"34","author":"Lye","year":"2013","journal-title":"Placenta"},{"issue":"11","key":"10.1016\/j.placenta.2020.07.012_bib95","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1139\/Y09-087","article-title":"Multidrug resistance phosphoglycoprotein (ABCB1) expression in the Guinea pig placenta: developmental changes and regulations by betamethasone","volume":"87","author":"Kalabis","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2 Suppl","key":"10.1016\/j.placenta.2020.07.012_bib96","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.taap.2005.02.023","article-title":"Role of transporters in placental transfer of drugs","volume":"207","author":"Ganapathy","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.placenta.2020.07.012_bib97","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.reprotox.2016.04.008","article-title":"Limited fetal metabolism of rosiglitazone: elimination via the maternal compartment in the pregnant Ewe","volume":"61","author":"Bazargan","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.placenta.2020.07.012_bib98","article-title":"Therapeutic drug monitoring in pregnant patients","author":"Johnson-Davis","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.placenta.2020.07.012_bib99","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2165\/00003088-198005040-00002","article-title":"Drug metabolism by the human fetus","volume":"5","author":"Juchau","year":"1980","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2165\/00003088-199121010-00005","article-title":"Fetal drug metabolism and its possible clinical implications","volume":"21","author":"Krauer","year":"1991","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.placenta.2020.07.012_bib101","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2165\/00003088-200241120-00003","article-title":"Ontogeny of hepatic and renal systemic clearance pathways in infants; Part I","volume":"41","author":"Alcorn","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"13","key":"10.1016\/j.placenta.2020.07.012_bib102","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003088-200241130-00005","article-title":"Ontogeny of hepatic and renal systemic clearance pathways in infants; Part II","volume":"41","author":"Alcorn","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbt.20179","article-title":"Ontogeny of human hepatic cytochromes P450","volume":"21","author":"Hines","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.placenta.2020.07.012_bib104","first-page":"1","article-title":"Overlapping between CYP3A4 and CYP3A7 expression in the fetal human liver during development","author":"Fanni","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bcp.2014.09.025","article-title":"Identification of CYP3A7 for glyburide metabolism in human fetal livers","volume":"92","author":"Shuster","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib107","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","article-title":"P-glycoprotein in the placenta: expression, localization, regulation and function","volume":"22","author":"Ceckova-Novotna","year":"2006","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib108","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0091270007311568","article-title":"P-glycoprotein: so many ways to turn it on","volume":"48","author":"Callaghan","year":"2008","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib109","doi-asserted-by":"crossref","first-page":"R478","DOI":"10.1152\/ajpregu.00138.2016","article-title":"Regulation of fetal liver growth in a model of diet restriction in the pregnant rat","volume":"311","author":"Boylan","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/dmd.112.046276","article-title":"Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone","volume":"41","author":"Choi","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib111","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/17425251003677755","article-title":"Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes","volume":"6","author":"Jeong","year":"2010","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib112","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/bcpt.12231","article-title":"Incorporation of flurbiprofen in a 4-drug cytochrome p450 phenotyping cocktail","volume":"115","author":"Bosilkovska","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.placenta.2020.07.012_bib113","doi-asserted-by":"crossref","first-page":"R1123","DOI":"10.1152\/ajpregu.00391.2017","article-title":"Improving pregnancy outcomes in humans through studies in sheep","volume":"315","author":"Morrison","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.placenta.2020.07.012_bib114","doi-asserted-by":"crossref","first-page":"839656","DOI":"10.1155\/2012\/839656","article-title":"Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?","volume":"2012","author":"Morrison","year":"2012","journal-title":"J. Pregnancy"},{"key":"10.1016\/j.placenta.2020.07.012_bib115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1203\/00006450-199712000-00015","article-title":"Impact of placental restriction of the development of the sympathoadrenal system","volume":"42","author":"Simonetta","year":"1997","journal-title":"Pediatr. Res."},{"issue":"Pt 2","key":"10.1016\/j.placenta.2020.07.012_bib116","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1113\/jphysiol.2004.080523","article-title":"Restriction of placental growth results in greater hypotensive response to alpha-adrenergic blockade in fetal sheep during late gestation","volume":"563","author":"Danielson","year":"2005","journal-title":"J. Physiol."},{"issue":"6579","key":"10.1016\/j.placenta.2020.07.012_bib117","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/bmj.294.6579.1051","article-title":"Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblasts in growth retarted fetuses","volume":"294","author":"Soothill","year":"1987","journal-title":"Br. Med. J."},{"issue":"1\u20132","key":"10.1016\/j.placenta.2020.07.012_bib118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/jpme.1991.19.1-2.97","article-title":"Metabolic and endocrine findings in appropriate and small for gestational age fetuses","volume":"19","author":"Economides","year":"1991","journal-title":"J. Perinat. Med."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib119","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000263348","article-title":"Plasma cortisol and adrenocorticotropom in appropriate and small for gestational age fetuses","volume":"3","author":"Economides","year":"1988","journal-title":"Fetal Ther."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9378(89)90453-5","article-title":"Blood glucose and oxygen tension levels in small-for-gestational-age fetuses","volume":"160","author":"Economides","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib121","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/0002-9378(89)90770-9","article-title":"Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses","volume":"161","author":"Nicolaides","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.07.012_bib122","doi-asserted-by":"crossref","first-page":"582748","DOI":"10.1155\/2012\/582748","article-title":"Impact of oxidative stress in fetal programming","volume":"2012","author":"Thompson","year":"2012","journal-title":"J. Pregnancy"},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib123","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.repbio.2018.09.002","article-title":"Reactive oxygen species mediated placental oxidative stress, mitochondrial content, and cell cycle progression through mitogen-activated protein kinases in intrauterine growth restricted pigs","volume":"18","author":"Luo","year":"2018","journal-title":"Reprod. Biol."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib124","first-page":"440","article-title":"Reactive oxygen species and oxidative DNA damage","volume":"42","author":"Hemnani","year":"1998","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.placenta.2020.07.012_bib125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clpt.2005.12.016","article-title":"Effect of maternal inflammation on the expression of ABCB1 and ABCG2 in placenta","volume":"79","author":"Wang","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.placenta.2020.07.012_bib126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","article-title":"Regulation of drug-metabolizing enzymes and transporters in inflammation","volume":"46","author":"Aitken","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.placenta.2020.07.012_bib127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fimmu.2018.00089","article-title":"The role of cytochromes P450 in infection","volume":"9","author":"Stavropoulou","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib128","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1470-2045(03)01034-9","article-title":"Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy","volume":"4","author":"Slaviero","year":"2003","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.placenta.2020.07.012_bib129","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0042-107078","article-title":"Maternal serum lipid, estradiol, and progesterone levels in pregnancy, and the impact of placental and hepatic pathologies","volume":"76","author":"Pecks","year":"2016","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","article-title":"H. National institute for child, U. Human development network of maternal-fetal-medicine, temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy","volume":"192","author":"Tracy","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.07.012_bib131","doi-asserted-by":"crossref","first-page":"e6368","DOI":"10.7717\/peerj.6368","article-title":"Intrauterine growth and the maturation process of adrenal function","volume":"7","author":"Iwata","year":"2019","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.placenta.2020.07.012_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20060339","article-title":"Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches","volume":"113","author":"Jansson","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.placenta.2020.07.012_bib133","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1290.016","article-title":"Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum","volume":"997","author":"Mastorakos","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.placenta.2020.07.012_bib134","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nm0595-460","article-title":"A placental clock controlling the length of human pregnancy","volume":"1","author":"McLean","year":"1995","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/03602532.2010.484462","article-title":"Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids","volume":"42","author":"Dvorak","year":"2010","journal-title":"Drug Metab. Rev."},{"issue":"10","key":"10.1016\/j.placenta.2020.07.012_bib136","first-page":"4979","article-title":"Reduced placental 11\u03b2-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms","volume":"86","author":"McTernan","year":"2001","journal-title":"J. Clin. Endrocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib137","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.placenta.2007.10.010","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery","volume":"29","author":"Dy","year":"2008","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib138","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcp.2006.01.007","article-title":"Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor","volume":"72","author":"Harper","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.placenta.2020.07.012_bib139","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cbi.2008.10.035","article-title":"Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes","volume":"179","author":"Vrzal","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"31","key":"10.1016\/j.placenta.2020.07.012_bib140","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.2174\/092986709789378198","article-title":"Synthetic and natural compounds that interact with human cytochrom P450 1A2 and implications in drug development","volume":"16","author":"Wang","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib141","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/17425255.2014.878703","article-title":"Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction","volume":"10","author":"Matoulkova","year":"2014","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"2","key":"10.1016\/j.placenta.2020.07.012_bib142","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920008783571774","article-title":"Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues","volume":"9","author":"Pavek","year":"2008","journal-title":"Curr. Drug Metabol."},{"issue":"23","key":"10.1016\/j.placenta.2020.07.012_bib143","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1113\/JP274948","article-title":"Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinic","volume":"596","author":"Morrison","year":"2018","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.placenta.2020.07.012_bib144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.semperi.2007.11.004","article-title":"An animal model of placental insufficiency-induced intrauterine growth restriction","volume":"32","author":"Barry","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"4","key":"10.1016\/j.placenta.2020.07.012_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/biolre\/iox012","article-title":"Placental transporter localization and expression in the human: the importance of species, sex and gestational age differences","volume":"96","author":"Walker","year":"2017","journal-title":"Biol. Reprod."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400420302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400420302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:01:46Z","timestamp":1758909706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400420302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":145,"alternative-id":["S0143400420302022"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2020.07.012","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of intrauterine growth restriction on cytochrome P450 enzyme expression and activity","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2020.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}